Inflammatory Pathways in Diabetes Biomarkers and Clinical Correlates /
This book discusses recent advances in new anti- and pro-inflammatory pathways in diabetic disease, and identifies new diagnostic immunological methods that offer potential companion diagnostics for diabetic diseases. New methods in proteomics, mass spectroscopy, immunological assay design, measurem...
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Cham :
Springer International Publishing : Imprint: Springer,
2015.
|
Έκδοση: | 1st ed. 2015. |
Σειρά: | Progress in Inflammation Research
|
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Part 1. Introduction
- 1. Impact of inflammation and the innate immunity response in obesity mediated diabetes (lit review)
- Part 2. Impact of complement on diabetic disease
- 2. Complement and Complement Regulatory Proteins in Diabetes
- Part 3. Role of C terminal fragment of adiponectin receptor in inhibition of insulin degradation
- 3. Development of adiponectin receptor C terminal fragment bioassays
- 4. Protease inhibition and biological distribution of the C terminal fragment of adiponectin receptor
- 5. Cell & biological models for the C terminal fragment of adiponectin receptor
- 6. C-Terminal fragment of adiponectin receptor clinical correlations
- Part 4. Uristatin assay for prediction of renal and other clinical events
- 7. Uristatin immunoassay usage in glomerular nephritis assessment
- 8. Acute Response of Uristatin in Surgery
- 9. Cardiovascular and metabolic syndrome impact on uristatin
- 10. Uristatin anti-inflammatory cellular signaling
- Part 5. Summary
- 11. Overview of progress in new markers for diabetes inflammation (Literatue Review).